Research Rationale BPC-157 upregulates angiogenic growth factors (VEGF, TGF-) to build vascular infrastructure TB-500 provides the actin-binding platform for cell migration into the repair site BPC-157 modulates nitric oxide synthesis and protects endothelial integrity, while TB-500 regulates inflammatory signalling and reduces oxidative stress The two peptides target separate phases of tissue repair: BPC-157 drives early-stage angiogenesis and granulation, TB-500 supports later-stage matrix remodelling Each compound is individually vialled and batch-traceable with independent COAs stack at your chosen concentrations Research Applications This stack is used in laboratory models of soft tissue repair, wound healing assays, endothelial cell migration studies, and inflammation-modulation research
This inherent stability extends to the sublingual space, where salivary enzymes pose far less threat to BPC-157 than they do to most peptides
TB-500 is a peptide related to thymosin beta-4, a naturally occurring protein in your body that is also involved in tissue repair
Secondary endpoints in trials include reductions in waist circumference , visceral fat mass, appetite scores, and daily caloric intake
Biomaterials 212 , 115125 (2019): Offeddu, G